Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
886.87
782.75
709.26
522.05
519.87
563.18
411.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
886.87
782.75
709.26
522.05
519.87
563.18
411.95
Raw Material Cost
516.44
501.87
425.26
299.72
387.95
313.27
259.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-23.09
-64.81
-1.00
36.08
-112.50
26.73
-13.14
Employee Cost
87.96
80.08
64.15
53.82
51.02
41.17
39.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
90.70
86.35
73.45
53.70
55.04
39.39
33.64
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
43.58
40.26
30.78
24.25
24.04
21.51
12.67
Total Expenditure (Excl Depreciation)
715.59
643.75
592.64
467.57
405.55
442.07
332.02
Operating Profit (PBDIT) excl Other Income
171.28
139.00
116.62
54.48
114.32
121.11
79.93
Other Income
8.35
6.22
4.46
4.91
5.20
3.45
5.11
Operating Profit (PBDIT)
179.63
145.22
121.08
59.39
119.52
124.56
85.04
Interest
23.08
18.54
23.46
21.91
18.88
11.16
12.21
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
156.55
126.68
97.62
37.48
100.64
113.40
72.83
Depreciation
39.92
34.34
31.52
32.13
32.15
22.28
22.07
Profit Before Tax
116.64
92.34
66.11
5.35
68.50
91.12
50.76
Tax
28.64
24.94
16.91
1.47
0.62
30.16
18.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
88.00
67.40
49.20
3.88
67.88
60.96
32.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
88.00
67.40
49.20
3.88
67.88
60.96
32.69
Share in Profit of Associates
13.99
1.74
0.63
-10.94
-5.66
1.56
-1.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
101.99
69.14
49.83
-7.06
62.22
62.53
31.57
Equity Capital
9.37
8.87
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
776.44
630.78
527.86
452.06
461.82
402.06
339.77
Earnings per share (EPS)
10.88
7.79
5.88
-0.83
7.35
7.38
3.73
Diluted Earnings per share
11.15
8.16
5.89
-0.83
7.35
7.39
3.73
Operating Profit Margin (Excl OI)
19.31%
17.76%
16.44%
10.44%
21.99%
21.5%
19.4%
Gross Profit Margin
17.65%
16.18%
13.76%
7.18%
19.36%
20.14%
17.68%
PAT Margin
9.92%
8.61%
6.94%
0.74%
13.06%
10.82%
7.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 13.30% vs 10.36% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 47.51% vs 38.75% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 23.22% vs 19.19% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 24.49% vs -20.97% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of SMS Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
886.87
538.66
348.21
64.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
886.87
538.66
348.21
64.64%
Raw Material Cost
516.44
17.46
498.98
2,857.85%
Purchase of Finished goods
0.00
285.35
-285.35
-100.00%
(Increase) / Decrease In Stocks
-23.09
-88.84
65.75
74.01%
Employee Cost
87.96
178.33
-90.37
-50.68%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
90.70
0.00
90.70
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
43.58
127.82
-84.24
-65.91%
Total Expenditure (Excl Depreciation)
715.59
520.12
195.47
37.58%
Operating Profit (PBDIT) excl Other Income
171.28
18.54
152.74
823.84%
Other Income
8.35
7.44
0.91
12.23%
Operating Profit (PBDIT)
179.63
25.98
153.65
591.42%
Interest
23.08
17.36
5.72
32.95%
Exceptional Items
0.00
-6.00
6.00
100.00%
Gross Profit (PBDT)
156.55
2.62
153.93
5,875.19%
Depreciation
39.92
82.45
-42.53
-51.58%
Profit Before Tax
116.64
-79.84
196.48
246.09%
Tax
28.64
-5.76
34.40
597.22%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
88.00
-74.08
162.08
218.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
88.00
-74.08
162.08
218.79%
Share in Profit of Associates
13.99
0.00
13.99
Minority Interest
0.00
0.14
-0.14
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
101.99
-73.94
175.93
237.94%
Equity Capital
9.37
34.63
-25.26
-72.94%
Face Value
1.00
10.00
0.00
Reserves
776.44
644.82
131.62
20.41%
Earnings per share (EPS)
10.88
-21.35
32.23
150.96%
Diluted Earnings per share
11.15
-22.46
33.61
149.64%
Operating Profit Margin (Excl OI)
19.31%
3.44%
0.00
15.87%
Gross Profit Margin
17.65%
0.49%
0.00
17.16%
PAT Margin
9.92%
-13.75%
0.00
23.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 886.87 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.30% vs 10.36% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 101.99 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.51% vs 38.75% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 171.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 23.22% vs 19.19% in Mar 2025
Annual - Interest
Interest 23.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 24.49% vs -20.97% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.31%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
